<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02468024</url>
  </required_header>
  <id_info>
    <org_study_id>STU 022015-069</org_study_id>
    <nct_id>NCT02468024</nct_id>
  </id_info>
  <brief_title>JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer</brief_title>
  <acronym>STABLE-MATES</acronym>
  <official_title>JoLT-Ca A Randomized Phase III Study of Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) in High Risk Patients With Stage I Non-Small Cell Lung Cancer (NSCLC), The STABLE-MATES Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Texas Southwestern Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Texas Southwestern Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To Determine if SAbR improves survival over SR in High Risk Operable Stage I NSCLC&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Stereotactic Ablative Radiotherapy has been shown in single institution phase II and matched&#xD;
      cohort studies to be effective at controlling primary early lung cancer. Recent pooled&#xD;
      analysis of both the STARS and ROSEL randomized trials comparing SABR versus lobectomy have&#xD;
      shown a significantly improved 3-year survival with SABR, giving further impetus for&#xD;
      successful completion of a randomized trial .&#xD;
&#xD;
      Pre-randomized trial- Patients will be screened and pre-randomized to either SR or SAbR.&#xD;
      Informed consent will be obtained after patients are made aware of the randomized assignment.&#xD;
      Despite pre-randomization prior to consent, patients maintain their right to accept or&#xD;
      decline any/all study activities. Only consenting patients will be allowed to participate in&#xD;
      study activities, including observation after either randomized treatments or observation&#xD;
      after standard of care treatment, while those declining consent will be managed by their&#xD;
      physician(s) off study.Patients will be accrued and followed for a minimum of 2-years after&#xD;
      treatment.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 2015</start_date>
  <completion_date type="Anticipated">December 2024</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Surgery versus SAbR</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>overall survival</measure>
    <time_frame>3 years</time_frame>
    <description>To test the hypothesis that the 3-year overall survival in high risk operable patients with Stage I NSCLC is greater in patient who undergo SAbR as compared to standard sublobar resection (SR).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>progression free survival</measure>
    <time_frame>5 years</time_frame>
    <description>survival at 5-years for Stage I NSCLC who undergo SR or SAbR.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>toxicity as assessed toxicity using the Common Toxicity Criteria</measure>
    <time_frame>3 years</time_frame>
    <description>toxicity using the Common Toxicity Criteria</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">272</enrollment>
  <condition>Non-Small Cell Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Arm 1 lung surgery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sublobar Resection (SR)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2 radiation therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Stereotactic Ablative Radiotherapy (SAbR)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Lung Surgery</intervention_name>
    <description>Sublobar Lung Resection</description>
    <arm_group_label>Arm 1 lung surgery</arm_group_label>
    <other_name>SR</other_name>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Radiation therapy</intervention_name>
    <description>Stereotactic Ablative Radiotherapy, 54 Gy in 3 fractions</description>
    <arm_group_label>Arm 2 radiation therapy</arm_group_label>
    <other_name>SAbR</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt; 18 years.&#xD;
&#xD;
          -  ECOG performance status (PS) 0, 1, or 2.&#xD;
&#xD;
          -  Radiographic findings consistent with non-small cell lung cancer, including lesions&#xD;
             with ground glass opacities with a solid component of 50% or greater. Those with&#xD;
             ground glass opacities and &lt;50% solid component will be excluded.&#xD;
&#xD;
          -  The primary tumor in the lung must be biopsy confirmed non-small cell lung cancer&#xD;
             within 180 days prior to randomization.&#xD;
&#xD;
          -  Tumor ≤ 4 cm maximum diameter, including clinical stage IA and selected IB by PET/CT&#xD;
             scan of the chest and upper abdomen performed within 180 days prior to randomization.&#xD;
             Repeat imaging within 90 days prior to randomization is recommended for re-staging but&#xD;
             is not required based on institutional norms.&#xD;
&#xD;
          -  All clinically suspicious mediastinal N1, N2, or N3 lymph nodes (&gt; 1 cm short-axis&#xD;
             dimension on CT scan and/or positive on PET scan) confirmed negative for involvement&#xD;
             with NSCLC by one of the following methods: mediastinoscopy, anterior mediastinotomy,&#xD;
             EUS/EBUS guided needle aspiration, CT-guided, video-assisted thoracoscopic or open&#xD;
             lymph node biopsy within 180 days of randomization.&#xD;
&#xD;
          -  Tumor verified by a thoracic surgeon to be in a location that will permit sublobar&#xD;
             resection.&#xD;
&#xD;
          -  Tumor located peripherally within the lung. NOTE: Peripheral is defined as not&#xD;
             touching any surface within 2 cm of the proximal bronchial tree in all directions. See&#xD;
             below. Patients with non-peripheral (central) tumors are NOT eligible.&#xD;
&#xD;
          -  No evidence of distant metastases.&#xD;
&#xD;
          -  Availability of pulmonary function tests (PFTs - spirometry, DLCO, +/- arterial blood&#xD;
             gases) within 180 days prior to registration. Patients with tracheotomy, etc, who are&#xD;
             physically unable to perform PFTs (and therefore cannot be tested for the Major&#xD;
             criteria in 3.1.11 below) are potentially still eligible if a study credentialed&#xD;
             thoracic surgeon documents that the patient's health characteristics would otherwise&#xD;
             have been acceptable for eligibility as a high risk but nonetheless operable patient&#xD;
             (in particular be eligible for sublobar resection).&#xD;
&#xD;
          -  Patient at high-risk for surgery by meeting a minimum of one major criteria or two&#xD;
             minor criteria&#xD;
&#xD;
          -  Major Criteria&#xD;
&#xD;
               -  FEV1 ≤ 50% predicted (pre-bronchodilator value)&#xD;
&#xD;
               -  DLCO ≤ 50% predicted (pre-bronchodilator value)&#xD;
&#xD;
          -  Minor Criteria&#xD;
&#xD;
               -  Age ≥75&#xD;
&#xD;
               -  FEV1 51-60% predicted (pre-bronchodilator value)&#xD;
&#xD;
               -  DLCO 51-60% predicted (pre-bronchodilator value)&#xD;
&#xD;
               -  Pulmonary hypertension (defined as a pulmonary artery systolic pressure greater&#xD;
                  than 40mm Hg) as estimated by echocardiography or right heart catheterization&#xD;
&#xD;
               -  Study credentialed thoracic surgeon believes the patient is potentially operable&#xD;
                  but that a lobectomy or pneumonectomy would be poorly tolerated by the patient&#xD;
                  for tangible or intangible reasons. The belief must be declared and documented in&#xD;
                  the medical record prior to randomization.&#xD;
&#xD;
               -  Poor left ventricular function (defined as an ejection fraction of 40% or less)&#xD;
&#xD;
               -  Resting or Exercise Arterial pO2 ≤ 55 mm Hg or SpO2 ≤ 88%&#xD;
&#xD;
               -  pCO2 &gt; 45 mm Hg&#xD;
&#xD;
               -  Modified Medical Research Council (MMRC) Dyspnea Scale ≥ 3.&#xD;
&#xD;
          -  No prior intra-thoracic radiation therapy for previously identified intra-thoracic&#xD;
             primary tumor (e.g. previous lung cancer) on the ipsilateral side. NOTE: Previous&#xD;
             radiotherapy as part of treatment for head and neck, breast, or other non-thoracic&#xD;
             cancer is permitted so long as possible radiation fields would not overlap. Previous&#xD;
             chemotherapy or surgical resection specifically for the lung cancer being treated on&#xD;
             this protocol is NOT permitted.&#xD;
&#xD;
          -  No prior lung resection on the ipsilateral side.&#xD;
&#xD;
          -  Non-pregnant and non-lactating. Women of child-bearing potential must have a negative&#xD;
             urine or serum pregnancy test prior to registration. Peri-menopausal women must be&#xD;
             amenorrheic &gt; 12 months prior to registration to be considered not of childbearing&#xD;
             potential.&#xD;
&#xD;
          -  No prior invasive malignancy, unless disease-free for ≥ 3 years prior to registration&#xD;
             (exceptions: non-melanoma skin cancer, in-situ cancers).&#xD;
&#xD;
          -  Ability to understand and the willingness to sign a written informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  evidence of distant metastases&#xD;
&#xD;
          -  prior intra-thoracic radiation therapy. NOTE: Previous radiotherapy as part of&#xD;
             treatment for head and neck, breast, or other non-thoracic cancer is permitted so long&#xD;
             as possible radiation fields would not overlap. Previous chemotherapy or surgical&#xD;
             resection specifically for the lung cancer being treated on this protocol is NOT&#xD;
             permitted. No prior lung resection on the ipsilateral side.&#xD;
&#xD;
          -  pregnant and lactating women&#xD;
&#xD;
          -  prior invasive malignancy, unless disease-free for ≥ 3 years prior to registration&#xD;
             (exceptions: non-melanoma skin cancer, in-situ cancers).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Timmerman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UTSW Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vaidehi Chemburkar</last_name>
    <phone>214-645-8525</phone>
    <email>Vaidehi.Chemburkar@utsouthwestern.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sarah Hardee, MS</last_name>
    <phone>214-645-8525</phone>
    <email>sarah.hardee@UTSouthwestern.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UCSD</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92023</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>University of Colorado/Memorial</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Penrose Cancer Center</name>
      <address>
        <city>Colorado Springs</city>
        <state>Colorado</state>
        <zip>80907</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Boca Raton Regional Hospital</name>
      <address>
        <city>Boca Raton</city>
        <state>Florida</state>
        <zip>33486</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Curtis and Elizabeth Anderson Cancer</name>
      <address>
        <city>Savannah</city>
        <state>Georgia</state>
        <zip>31404</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aaron Pederson</last_name>
      <phone>912-350-8490</phone>
    </contact>
    <contact_backup>
      <last_name>Lisa Morgan</last_name>
      <phone>912-350-8490</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Memorial Health University Medical Center</name>
      <address>
        <city>Savannah</city>
        <state>Georgia</state>
        <zip>31404</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aaron Pederson, MD</last_name>
      <phone>912-350-8490</phone>
    </contact>
    <contact_backup>
      <last_name>Lisa Morgan</last_name>
      <phone>912-350-8490</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of Iowa</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Kansas Medical Center</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Kentucky Health Care</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40536-0093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>University of Louisville Physicians</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neal Dunlap, MD</last_name>
      <phone>502-588-6000</phone>
    </contact>
    <contact_backup>
      <last_name>Teresa Roberts</last_name>
      <phone>502-588-6000</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Ochsner Medical Center</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70121</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Anne Arundel Oncology Center</name>
      <address>
        <city>Annapolis</city>
        <state>Maryland</state>
        <zip>21401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Young, MD</last_name>
      <phone>443-481-1000</phone>
    </contact>
    <contact_backup>
      <last_name>Steven DeMartino</last_name>
      <phone>443-481-1000</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of Maryland Medical Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Boston Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02118</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kei Suzuki, MD</last_name>
      <email>Kei.Suzuki@bmc.org</email>
    </contact>
    <contact_backup>
      <last_name>Yoma Akpoviroro</last_name>
      <email>OGHENEYOMA.Akpoviroro@bmc.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Henry Ford Health System</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202-2689</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Beaumont</name>
      <address>
        <city>Royal Oak</city>
        <state>Michigan</state>
        <zip>48073</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Meridian Health System</name>
      <address>
        <city>Neptune</city>
        <state>New Jersey</state>
        <zip>07753</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Bauer, MD</last_name>
      <email>thomas.bauer@hackensackmeridian.org</email>
    </contact>
    <contact_backup>
      <last_name>Lori Bernard</last_name>
      <email>Lori.Bernard@hmhn.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>New York University Langone Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benjamin Cooper, MD</last_name>
      <email>Benjamin.Cooper@nyulangone.org</email>
    </contact>
    <contact_backup>
      <last_name>Marjana Begum</last_name>
      <email>Marjana.Begum@nyulangone.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>SUNY - Upsate Medical Centre</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeffrey Bogart, MD</last_name>
      <email>BogartJ@upstate.edu</email>
    </contact>
    <contact_backup>
      <last_name>Erin Bingham</last_name>
      <email>BinghamE@upstate.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of North Carolina</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Wake Forest Baptist Health</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>University of Cincinnati</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45267</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Case Western (University Hospitals Case Medical Center)</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philip Linden, MD</last_name>
      <email>Philip.Linden@UHhospitals.org</email>
    </contact>
    <contact_backup>
      <last_name>Ellen Perme</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ohio State University Wexner Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Merritt, MD</last_name>
      <phone>614-293-8415</phone>
      <email>Robert.Meritt@osumc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Catherine Schweitzer</last_name>
      <phone>614-293-8415</phone>
      <email>Catherine.Schweitzer@osumc.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Providence Health &amp; Services/Oregon Clinic</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Allegheny</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benny Weksler, MD</last_name>
      <email>Benny.Weksler@AHN.org</email>
    </contact>
    <contact_backup>
      <last_name>Jessica Aritonovich</last_name>
      <email>Jessica.Aritonovich@AHN.ORG</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>UPMC Health System</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15234</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James D Luketich</last_name>
      <phone>412-363-7383</phone>
    </contact>
    <contact_backup>
      <last_name>Julie Ward</last_name>
      <phone>412-363-7383</phone>
      <email>wardj@upmc.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Mount Nittany</name>
      <address>
        <city>State College</city>
        <state>Pennsylvania</state>
        <zip>16803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Lifespan Oncology Clinical Research</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02903</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>University of Tennessee Health Science Center</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38163</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Noam VanderWalde, MD</last_name>
      <phone>901-448-2918</phone>
      <email>nvanderw@WESTCLINIC.com</email>
    </contact>
    <contact_backup>
      <last_name>Catherine Morningstar</last_name>
      <phone>901-448-2918</phone>
      <email>cmorningstar@WESTCLINIC.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Cardiothoracic and Vascular Surgeons</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachel Medbery, MD</last_name>
      <email>rmedbery@ctvstexas.com</email>
    </contact>
    <contact_backup>
      <last_name>Bonnie Punske</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vaidehi Chemburkar</last_name>
      <phone>214-645-8525</phone>
      <email>Vaidehi.Chemburkar@utsouthwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Robert Timmerman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Intermountain Medical Center</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Griffin, MD</last_name>
      <email>David.Griffin@imail.org</email>
    </contact>
    <contact_backup>
      <last_name>Katie Meents</last_name>
      <email>Katie.Meents@imail.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of Virginia Health System</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22901</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Inova Fairfax Medical Campus</name>
      <address>
        <city>Falls Church</city>
        <state>Virginia</state>
        <zip>22042</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Swedish Cancer Institute</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brian Louie, MD</last_name>
      <phone>206-215-6800</phone>
    </contact>
    <contact_backup>
      <last_name>Andrew Smith</last_name>
      <phone>206-215-6800</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Medical College of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Johnstone, MD</last_name>
      <email>djohnstone@mcw.edu</email>
    </contact>
    <contact_backup>
      <last_name>Madiha Arshad</last_name>
      <email>Marshad@mcw.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Clement Zablocki VA Medical Center</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53295</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Gore, MD</last_name>
      <phone>414-384-2000</phone>
    </contact>
    <contact_backup>
      <last_name>Shelly Dufek</last_name>
      <phone>414-384-2000</phone>
      <email>Shelley.Dufek@va.gov</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Milwaukee VA Medical Center</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53295</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Gore, MD</last_name>
      <email>EGore@mcw.edu</email>
    </contact>
    <contact_backup>
      <last_name>Shelley Dufek</last_name>
      <email>Shelley.Dufek@VA.gov</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>St. Vincent's/Peter Mac</name>
      <address>
        <city>Fitzroy</city>
        <state>Victoria</state>
        <zip>3065</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gavin Wright, MD</last_name>
      <email>Gavin.WRIGHT@svha.org.au</email>
    </contact>
    <contact_backup>
      <last_name>Jane Mack</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Lawson Health Science Center</name>
      <address>
        <city>London</city>
        <state>Ontario, Canada</state>
        <zip>N6C 2R5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Malthaner</last_name>
      <phone>519-646-6005</phone>
    </contact>
    <contact_backup>
      <last_name>Deb Lewis</last_name>
      <phone>519-646-6005</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Ottawa Hospital Cancer Center</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>KIH8L6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sebastien Gilbert, MD</last_name>
      <email>sgilbert@toh.ca</email>
    </contact>
    <contact_backup>
      <last_name>Anna Fazekas</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>UHN-Toronto</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G2C4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gail Darling, MD</last_name>
      <phone>416-340-3131</phone>
    </contact>
    <contact_backup>
      <last_name>Jennifer Lister</last_name>
      <phone>416-340-3131</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>CHUM</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>26214</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Moishe Liberman, MD</last_name>
      <phone>514 890-8000</phone>
    </contact>
    <contact_backup>
      <last_name>Adeline Jouquan</last_name>
      <phone>514 890-8000</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Trillium Health Partners</name>
      <address>
        <city>Mississauga</city>
        <zip>L5M 2N1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anthony Brade, MD</last_name>
      <phone>(905) 813-2200</phone>
    </contact>
    <contact_backup>
      <last_name>Sandy Philliips</last_name>
      <email>sandy.phillips@THP.CA</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Sunnybrook Health Sciences Centre</name>
      <address>
        <city>Toronto</city>
        <zip>M4N 3M5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick Cheung, MD</last_name>
      <phone>416-480-5000</phone>
    </contact>
    <contact_backup>
      <last_name>Ilda Carvalhana</last_name>
      <phone>416-480-5000</phone>
    </contact_backup>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>June 1, 2015</study_first_submitted>
  <study_first_submitted_qc>June 5, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 10, 2015</study_first_posted>
  <last_update_submitted>September 28, 2021</last_update_submitted>
  <last_update_submitted_qc>September 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Texas Southwestern Medical Center</investigator_affiliation>
    <investigator_full_name>Robert Timmerman</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

